European GDP Association nominates new Advisory Board Member
Dr Laura Ribeiro, who is a Responsible Person at ID Logistics (formerly Logiters) in Portugal, has recently accepted her nomination as the fifth member of the GDP Association's Board. Prior to her position at ID Logistics she was R&D and regulatory affairs manager in the pharmaceutical industry, invited Professor at Escola Superior de Tecnologias da Saúde de Coimbra and later deputy Technical Director at Logiters, being responsible for quality and GDP related activities.
"I am pleased that Laura accepted our invitation to join the ECA GDP Board" said Dr Afshin Hosseiny, GDP Association Advisory Board Chairman. "GDP is a developing subject for the pharma industry, and I am really excited that our team can have a positive influence in the future both on developing industry understanding and providing supporting guidelines for the practitioners. Laura's professional experience will be a very valuable addition to our team." "I felt honoured about the invitation to join the Association's Advisory Board" Dr Laura Ribeiro stated upon her nomination. "And I very much look forward to working with the other members to help advance the group".
Read more about the Advisory Board Members of the European GDP Association at www.good-distribution-practice-group.org.
About the GDP Association
The Good Distribution Practice Group was founded in March 2013 – then as an Interest Group. In November 2016 it was transferred to the European GDP Association and today counts close to 1.900 members from almost 80 countries. The Association represents all stakeholders e.g. from Pharmaceutical Industry, Authorities and Logistic Providers and supports them by providing them with information about the implementation of GDP. Although it has a strong focus on European GDP Regulations and their implementation into the different EU member states, it also supports harmonisation of the requirements with other regions of the world - wherever medicinal products, APIs, Excipients, etc are distributed.
The Association is a not for profit organisation under the umbrella of the ECA Foundation. Due to this support, the European GDP Association is able to offer a free membership to all individuals involved in Good Distribution Practice. To find out more please visit www.good-distribution-practice-group.org.
About the ECA Foundation
Founded as an independent not for profit organisation in 1999, the ECA Foundation is Europe’s leading association for pharmaceutical Quality Assurance and GMP compliance. Its goal is “the exchange of information between representatives of the industry, regulatory authorities and universities in the field of pharmaceutical quality assurance, especially with regard to the area of Good Manufacturing Practice (GMP).” For that purpose the organisation has set up several Interest Groups and Working Groups as well as an Academy for advanced education. Individuals can become member of the ECA Groups and in the Academy. In total more than 7.000 professionals have joined the ECA organisation. Its largest group, the European Qualified Person Association, alone counts close to 2.400 QPs. The ECA Foundation Groups developed a range of tools like several Good Practice Guides. For further information on the ECA Foundation please visit www.eca-foundation.org.
P.O. Box 10 21 68
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release European GDP Association nominates new Advisory Board Member here
News-ID: 623457 • Views: 476
More Releases from ECA Foundation
Paul-Ehrlich-Institute and ECA Foundation jointly organise 2-day Workshop – Go …
Vaccine development and deployment are crucial to control the COVID-19 pandemic. Platform technologies have enabled rapid development of vaccines with demonstrated efficacy against COVID-19. However, large-scale manufacturing is both a prerequisite and a challenge in meeting the global demand. This implies upscaling of manufacturing, meeting Good Manufacturing Practice (GMP) requirements, and switching of manufacturing in existing facilities. The workshop organised by the Paul-Ehrlich-Institut and the ECA Foundation will address these
ECA Foundation added to EMA List of Stakeholder Organisations
The ECA Foundation is now listed in the European Medicines Agency's (EMA) list of eligible industry stakeholder organisations (www.ema.europa.eu/en/documents/other/list-eligible-industry-stakeholder-organisations_en.pdf). Pre-requisite for this entry is the listing in the EU's Transparency Register (http://ec.europa.eu/transparencyregister/public/consultation/searchControllerPager.do?declaration=ECA%20Foundation&search=search&locale=en#en) - where the ECA has been registered since January 2019. The ECA Foundation is the leading European organisation with regard to pharmaceutical Quality Assurance and GMP compliance. The ECA Foundation is a not for profit organisation. The ECA is headed
ECA Foundation announces Independent Authority Board (IAB) Members
Since June 2015 the ECA Foundation, the leading European organisation in the pharmaceutical quality assurance and GMP compliance environment, has been managed by an Executive Board and an Extended Board. In addition, the ECA set up an Advisory Committee encompassing authority representatives. Now the Foundation announced the members of the Independent Authority Board (IAB). It is one of the ECA Foundation’s major objectives to discuss GMP developments with the stakeholders
ECA’s Working Group “Visual Inspections” nominates Chair
Although the Pharmacopoeias provide some information relative to visual inspections of parenterals, there is no substantial GMP regulation – neither in the Europe nor in the US. As a result there are ongoing discussions with regard to issues like AQL testing, use of testing kits, qualification/validation/verification of automated systems and training of the manual visual inspection staff. For that reason the ECA Foundation established its “Visual Inspections” Working Group in
More Releases for GDP
IATA's CEIV-Pharma Certification or HSA's GDP Certification?
Players throughout the pharmaceutical supply chain are experiencing growing pressure to gain accreditation for handling the high-value, temperature-sensitive cargo, as having a certification becomes more commonplace, rather than an exceptional feat in the industry. There are currently 2 different measures of standards, one is IATA's CEIV-Pharma Certification and the other is HSA's GDP Certification. There are major players on both sides of the fence which hold – GDP-compliant certificates and CEIV-pharma certifications.
Exploring the recent PQG / ECA guide to GDP
The Pharmaceutical Quality Group (PQG) issued a monograph on Pharmaceutical Distribution in 1997 and initiated planning to revise this in line with the new EU GDP regulatory guideline (a final revised version was issued in March 2013 with an effective date of 8 September 2013). Although the 2013 EU-GDP guidelines provide far more details than previous guidelines, it is clear that there was and is a need for further guidance on
Economic & Retail Updated: GDP, interest rates, market size and forecast
Summary As the impact of the shock EU referendum result begins to be realised, the UK economy will feel the brunt with inflation rising and consumer confidence remaining low. This report provides an overview of the key economic indicators such as GDP, interest rates, unemployment and the housing market, and the subsequent impact on consumer confidence and retail growth and projections. The Economic & Retail Update Q1 2017 report provides an executive-level
Is demonetization responsible for lower GDP growth rate?
Decimal Point Analytics has released an weekly digest on 4th September titled ‘Is demonetization responsible for lower GDP growth rate?’ In this piece, Decimal point has weighed upon the recent announcement of GDP numbers which has been below market expectation. Its arguments are counter to the popular consensus, that demonetization has been the prime reason for this considerable fall in GDP. The author has highlighted the fact that it’s the businesses
US GDP Up 1.7% Shattering Economists Predictions
Aug. 01, 2013 - HONG KONG -- On Wednesday the US Commerce Department released its highly anticipated report on GDP, stating that in the second quarter the US economy grew 1.7% driven by an increase of 1.8% in consumer spending and 9% in business investment. New home construction was another important driver of growth, with investment rising 13.4%, the fourth consecutive increase. This gain beat expectations of a 1%
Taiwan's GDP growth to hit fastest pace in 21 years
By Audrey Wang The Economist Intelligence Unit expects Taiwan’s gross domestic product to grow by 9.2 percent in 2010, the fastest rate in 21 years, according to the Council for Economic Planning and Development Sept. 24. The EIU report noted that Taiwan’s economy grew by an average of 13.1 percent in the first two quarters of 2010. This stellar performance, the EIU said, “largely reflects the global economy’s return to